In early March 2026, Viking Therapeutics announced that it had recently participated in several investor conferences, including the Leerink Partners Global Healthcare Conference 2026 and the Jefferies ...

Viking Holdings Ltd. reported robust financial results for the fourth quarter of 2025, surpassing earnings expectations with an adjusted EPS of $0.67, significantly higher than the forecasted $0.48.

Analysts on Wall Street project that Viking Holdings (VIK) will announce quarterly earnings of $0.54 per share in its forthcoming report, representing an increase of 20% year over year. Revenues are ...

Viking Therapeutics Inc. reported a significant miss in its Q4 2025 earnings, with an earnings per share (EPS) of -$1.38, falling short of the -$0.9 forecast. This 53.33% negative surprise contributed ...